Indianapolis, May 4, 2026, 09:01 EDT
Corteva on Monday unveiled the name for its upcoming advanced seed and genetics spinoff: Vylor, Inc. That puts a brand to the business set to split from Corteva’s crop-protection division in the fourth quarter of 2026. Until now, the company just called it “SpinCo.” Corteva Agriscience
The name’s in focus now, as the breakup shifts from talk to action—with farmers, staff, and investors all keeping tabs. Under the plan, Vylor will take on seeds and genetics. What’s left of Corteva sticks with crop protection: herbicides, fungicides, insecticides, and biologicals.
Vylor accounts for the bulk of the split. Corteva’s seed business reported $9.90 billion in net sales for 2025, compared to roughly $7.50 billion from crop protection, according to company results.
Corteva’s Vylor spinoff launches carrying over 4,000 germplasm patents and upwards of 2,000 biotech patents on day one. That germplasm—basically the genetic foundation for seed breeding—anchors a R&D pipeline that includes hybrid wheat, gene editing, and corn designed to resist multiple diseases, the company said.
Chuck Magro, who’s set to become Vylor’s CEO, pointed to the company’s origins in the conviction that science has the power to reshape agriculture. “That belief remains our North Star,” he said. Magro, now the chief executive at Corteva, will step into the new role once the seed company’s separation is finalized. Corteva Agriscience
Corteva rolled out its seed company leadership lineup last month, tapping David Johnson for CFO, Judd O’Connor for chief commercial and operations officer, and Sam Eathington as CTO. The group has an investor day on the calendar for Sept. 15 at the New York Stock Exchange.
The crop-protection company sticking with the Corteva name is set to be led by Luther “Luke” Kissam, who previously served as Albemarle’s chairman, president and CEO. Greg Page steps in as chair following the split, according to the company. PR Newswire
Corteva hovered near $80.85 in premarket action, barely budging, and putting its market cap around $54.6 billion. Wolfe Research bumped its target up to $89 and stuck with its Outperform call, according to Investing.com.
The split lines up two specialized companies against Corteva’s current all-in-one approach. Vylor, on the seeds side, faces heavyweight competition from Bayer. Crop protection is another story—Corteva goes up against Syngenta, BASF, and Bayer, according to Reuters.
Risks are front and center. Bank of America’s Matthew DeYoe has flagged the split as lacking “clear strategic or financial merit,” warning that both arms could end up weaker as a result. His main worry: research ties between seeds and crop chemicals could fray, threatening products like the Enlist weed-control system. Reuters
Corteva flagged a list of risks tied to the separation: it might not deliver on its goals, could run past the company’s timeline, and may trigger surprise expenses, lawsuits, or disruptions affecting employees, suppliers, and customers. Typical carve-out concerns, but for a business selling to farmers on lengthy product cycles, they carry extra weight.
Next up: substantive moves. Investors are still waiting on more detailed separation filings, capital breakdowns, and independent performance targets—essentials for valuing both Vylor and what’s left of Corteva. At this stage, the new name simply brands the seed business, but the market hasn’t assigned a value yet.
